Virtus ETF Advisers LLC - MADRIGAL PHARMACEUTICALS INC ownership

MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 142 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.

Quarter-by-quarter ownership
Virtus ETF Advisers LLC ownership history of MADRIGAL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$56,664
-42.1%
388
-8.5%
0.03%
-41.4%
Q2 2023$97,944
-76.7%
424
-75.5%
0.06%
-74.9%
Q1 2023$419,837
-39.7%
1,733
-27.8%
0.23%
-36.5%
Q4 2022$696,310
+603.3%
2,399
+57.9%
0.36%
+833.3%
Q3 2022$99,000
-8.3%
1,519
+1.0%
0.04%
-2.5%
Q2 2022$108,000
-48.6%
1,504
-29.7%
0.04%
-57.4%
Q1 2022$210,000
+9.4%
2,139
-5.8%
0.09%
+28.8%
Q4 2021$192,000
+21.5%
2,270
+14.9%
0.07%
+4.3%
Q3 2021$158,000
-21.8%
1,976
-4.9%
0.07%
-15.7%
Q2 2021$202,000
-30.3%
2,078
-16.2%
0.08%
-32.0%
Q1 2021$290,000
+6.6%
2,480
+1.5%
0.12%
+8.0%
Q4 2020$272,000
-20.5%
2,444
-15.1%
0.11%
-36.9%
Q3 2020$342,000
-8.1%
2,879
-12.4%
0.18%
+1.7%
Q2 2020$372,000
+51.2%
3,287
-10.8%
0.18%
+74.3%
Q1 2020$246,000
-36.1%
3,683
-12.8%
0.10%
+60.3%
Q4 2019$385,000
+71.9%
4,226
+62.5%
0.06%
+40.0%
Q3 2019$224,000
-22.2%
2,600
-5.2%
0.04%
-26.2%
Q2 2019$288,000
-5.3%
2,744
+1.6%
0.06%
+17.3%
Q4 2018$304,000
-10.1%
2,700
+71.1%
0.05%
+48.6%
Q3 2018$338,000
-55.2%
1,578
-41.5%
0.04%
-94.8%
Q2 2018$755,000
-32.9%
2,699
-72.0%
0.67%
-31.7%
Q1 2018$1,125,000
+179.9%
9,629
+119.7%
0.98%
+93.7%
Q4 2017$402,0004,3820.50%
Other shareholders
MADRIGAL PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Tao Capital Management LP 77,657$5,047,0003.31%
L1 Capital Pty Ltd 161,163$10,474,0002.05%
Avoro Capital Advisors LLC 1,535,000$99,760,0001.84%
Affinity Asset Advisors, LLC 100,000$6,499,0001.81%
GREAT POINT PARTNERS LLC 95,500$6,207,0001.50%
ARMISTICE CAPITAL, LLC 1,236,000$80,328,0001.39%
Affinity Asset Advisors, LLC 75,000$4,874,0001.36%
MPM BioImpact LLC 44,747$2,908,0000.69%
Baker Brothers Advisors 1,499,213$97,434,0000.64%
Perceptive Advisors 331,023$21,513,0000.62%
View complete list of MADRIGAL PHARMACEUTICALS INC shareholders